NMRA vs NSC · $283.5M cap vs P/E 18, rev $12.12B
Neumora Therapeutics, Inc. (NMRA) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported NSC revenue for 2024-12-31 was $12.12B. Net income was $2.62B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
NMRA currently screens at market cap $283.5M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the NMRA and NSC stock pages for the full models.
Not investment advice.